imiquimod has been researched along with Cancer of Nose in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ged, C; Hernández-Martín, A; Knöpfel, N; Latour, I; Taïeb, A; Torrelo, A | 1 |
| Ishiuji, Y; Nakagawa, H; Nobeyama, Y | 1 |
| de Vries, K; Greveling, K; Prens, EP; van Doorn, MB | 1 |
| Butler, DF; Lenis, A; Parekh, PK | 1 |
| Baskan, EB; Saricaoglu, H; Toker, SC; Tunali, S; Turan, A | 1 |
| Breuninger, H; Häfner, HM; Moehrle, M; Schippert, W | 1 |
| Balsamo, G; Calvieri, S; Cantisani, C; Frati, R; Mattozzi, C; Melis, L; Richetta, AG | 1 |
| Bassukas, ID; Gaitanis, G; Kalogeropoulos, C | 1 |
| Aebi, S; Caversaccio, M | 1 |
| Denkler, K; Kivett, WF | 1 |
| Li, LJ; Wagamon, K | 1 |
| Assimakopoulos, DA; Benton, J; Fika, Z; Karkos, PD | 1 |
| Amat, M; Fernández-Casado, A; Gallardo, F; Pujol, RM | 1 |
1 review(s) available for imiquimod and Cancer of Nose
| Article | Year |
|---|---|
Retiform hemangioendothelioma treated with conservative therapy: report of a case and review of the literature.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Glucocorticoids; Hemangioendothelioma; Humans; Imiquimod; Injections, Intralesional; Lasers, Dye; Male; Nose Neoplasms; Skin Neoplasms; Triamcinolone Acetonide | 2016 |
1 trial(s) available for imiquimod and Cancer of Nose
| Article | Year |
|---|---|
Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Double-Blind Method; Female; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Nose Neoplasms; Ointments | 2009 |
11 other study(ies) available for imiquimod and Cancer of Nose
| Article | Year |
|---|---|
Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Child, Preschool; Eyelid Neoplasms; Humans; Imiquimod; Male; Nose Neoplasms; Skin Neoplasms; Xeroderma Pigmentosum | 2018 |
A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy; Leg; Male; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms; Treatment Outcome | 2016 |
Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Therapy, Combination; Female; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Middle Aged; Nose Neoplasms; Recombinant Proteins; Skin Neoplasms | 2009 |
Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Neoadjuvant Therapy; Nose Neoplasms; Skin Neoplasms | 2010 |
Ulcerated nodular nasal basal cell carcinoma successfully treated with imiquimod 5% cream.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Nose Neoplasms | 2011 |
Imiquimod can be combined with cryosurgery (immunocryosurgery) for locally advanced periocular basal cell carcinomas.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Eyelid Neoplasms; Facial Neoplasms; Female; Humans; Imiquimod; Male; Nose Neoplasms | 2011 |
Medical treatment of nasal squamous papilloma with imiquimod cream.
Topics: Aminoquinolines; Humans; Imiquimod; Immunity, Cellular; Immunocompromised Host; Interferon Inducers; Male; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms; Ointments; Papilloma; Treatment Outcome | 2003 |
Topical treatment of nasal keratoacanthoma.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Keratoacanthoma; Middle Aged; Nose Neoplasms; Treatment Outcome | 2006 |
Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Nasal Cavity; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms | 2007 |
Conservative management of recurrent nasal squamous papilloma with topical immunomodulators.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Squamous Cell; Humans; Imiquimod; Nose Neoplasms; Papilloma | 2007 |
Successful treatment of intranasal papillomata with imiquimod cream in a human immunodeficiency virus positive patient.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; HIV Seropositivity; Humans; Imiquimod; Male; Nose Neoplasms; Papilloma; Treatment Outcome | 2009 |